Silencing synuclein at the synapse with PLK2

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 41, 2013, Pages 16293-16294

  Looyenga, Brendan D ^a,b   Brundin, Patrik ^b  

^a CALVIN COLLEGE   (United States)

^b VAN ANDEL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ALPHA SYNUCLEIN; AMPA RECEPTOR; ASPARTIC ACID; CALCIUM; MICRORNA; POLO LIKE KINASE 2; POLO LIKE KINASE 3; SERINE; SMALL INTERFERING RNA; SYNUCLEIN;

AUTOPHAGY; BRAIN; CALCIUM HOMEOSTASIS; CELL CULTURE; CELL SURVIVAL; CELL TRANSFER; DEGENERATIVE DISEASE; DRUG SCREENING; GENE EXPRESSION; GENE MUTATION; GENE SILENCING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LEWY BODY; LOSS OF FUNCTION MUTATION; NERVE CELL; NEUROPATHOLOGY; NONHUMAN; NOTE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN SECRETION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; SYNAPSE; SYNAPTOSOME;

ALPHA-SYNUCLEIN; ANIMALS; GENE EXPRESSION REGULATION; HUMANS; PARKINSON DISEASE; PROTEIN-SERINE-THREONINE KINASES; PROTEOLYSIS;

EID: 84885366756     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1315622110     Document Type: Note

References (21)

1. Forno LS, et al. (1986) Reaction of Lewy bodies with antibodies to phosphorylated and non-phosphorylated neurofilaments. Neurosci Lett 64(3):253-258.
2. Bancher C, et al. (1989) An antigenic profile of Lewy bodies: Immunocytochemical indication for protein phosphorylation and ubiquitination. J Neuropathol Exp Neurol 48(1): 81-93.
3. Okochi M, et al. (2000) Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein. J Biol Chem 275(1): 390-397.
4. Nakajo S, Tsukada K, Omata K, Nakamura Y, Nakaya K (1993) A new brain-specific 14-kDa protein is a phosphoprotein. Its complete amino acid sequence and evidence for phosphorylation. Eur J Biochem 217(3):1057-1063.
5. Sato H, Kato T, Arawaka S (2013) The role of Ser129 phosphorylation of α-synuclein in neurodegeneration of Parkinson's disease: A review of in vivo models. Rev Neurosci 24(2): 115-123.
6. Oueslati A, Schneider BL, Aebischer P, Lashuel HA (2013) Polo-like kinase 2 regulates selective autophagic α-synuclein clearance and suppresses its toxicity in vivo. Proc Natl Acad Sci USA 110: E3945-E3954.
7. Inglis KJ, et al. (2009) Polo-like kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in central nervous system. J Biol Chem 284(5):2598-2602.
8. Mbefo MK, et al. (2010) Phosphorylation of synucleins by members of the Polo-like kinase family. J Biol Chem 285(4): 2807-2822.
9. Elia AE, et al. (2003) The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain. Cell 115(1):83-95.
10. Pronin AN, Morris AJ, Surguchov A, Benovic JL (2000) Synucleins are a novel class of substrates for G protein-coupled receptor kinases. J Biol Chem 275(34):26515-26522.
11. Kauselmann G, et al. (1999) The polo-like protein kinases Fnk and Snk associate with a Ca(2+)-and integrin-binding protein and are regulated dynamically with synaptic plasticity. EMBO J 18(20): 5528-5539.
12. Simmons DL, Neel BG, Stevens R, Evett G, Erikson RL (1992) Identification of an early-growth-response gene encoding a novel putative protein kinase. Mol Cell Biol 12(9):4164-4169.
13. Pak DT, Sheng M (2003) Targeted protein degradation and synapse remodeling by an inducible protein kinase. Science 302(5649):1368-1373.
14. Seeburg DP, Feliu-Mojer M, Gaiottino J, Pak DT, Sheng M (2008) Critical role of CDK5 and Polo-like kinase 2 in homeostatic synaptic plasticity during elevated activity. Neuron 58(4):571-583.
15. Paillusson S, Clairembault T, Biraud M, Neunlist M, Derkinderen P (2013) Activity-dependent secretion of alpha-synuclein by enteric neurons. J Neurochem 125(4):512-517.
16. Lee BR, Matsuo Y, Cashikar AG, Kamitani T (2013) Role of Ser129 phosphorylation of α-synuclein in melanoma cells. J Cell Sci 126(Pt 2): 696-704.
17. Brundin P, Li JY, Holton JL, Lindvall O, Revesz T (2008) Research in motion: The enigma of Parkinson's disease pathology spread. Nat Rev Neurosci 9(10):741-745.
18. Trinh J, Farrer M (2013) Advances in the genetics of Parkinson disease. Nat Rev Neurol 9(8):445-454.
19. Tofaris GK (2012) Lysosome-dependent pathways as a unifying theme in Parkinson's disease. Mov Disord 27(11):1364-1369.
20. Luk KC, et al. (2012) Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338(6109):949-953.
21. Verkhratsky A (2005) Physiology and pathophysiology of the calcium store in the endoplasmic reticulum of neurons. Physiol Rev 85(1):201-279.